COSMC-Regulated O-Glycosylation: A Bioinformatics-Driven Biomarker Identification for Stratifying Glioblastoma Stem Cell Subtypes
Glioblastoma stem cells (GSCs) are key drivers of relapse, metastasis, and therapy resistance in glioblastoma due to their adaptability and diversity, which make them challenging to target effectively. This study explores the O-glycosylation in differentiating two key GSC subtypes, CD133 and CD44. W...
Saved in:
Main Authors: | Sara Sadat Aghamiri, Rada Amin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Kinases and Phosphatases |
Subjects: | |
Online Access: | https://www.mdpi.com/2813-3757/2/4/25 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ligands of CD6: roles in the pathogenesis and treatment of cancer
by: Mikel Gurrea-Rubio, et al.
Published: (2025-01-01) -
Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
by: Jian‐Hua Wang, et al.
Published: (2019-03-01) -
CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation
by: Peter Tobias Felixberger, et al.
Published: (2025-02-01) -
Evaluating the role of CD44 in oral squamous cell carcinoma and potentially malignant disorders – An immunohistochemical study
by: Tharani V, et al.
Published: (2024-06-01) -
Investigation of Hyaluronan Synthase 2 and CD44 immune reactivity as a biomarker to predict Progesterone-Resistant Endometrial Hyperplasia without atypia: A retrospective case-control study
by: Emine Boybay, et al.
Published: (2024-12-01)